Brilliant Violet 421TM anti-human CD40 [5C3] and 5 more items

The University of Virginia has awarded a purchase order (A207_PO-0435782-V2) to BioLegend Inc., a life sciences reagent supplier, effective June 5, 2026. The contract totals $617.00 and encompasses the procurement of six monoclonal antibody products for delivery to Jing Gao at the University of Virginia. The line items include flow cytometry reagents such as Brilliant Violet 421 anti-human CD40, APC anti-human CD274 (programmed death-ligand 1), and APC anti-human CD142, along with corresponding isotype control antibodies necessary for immunological research applications.

These fluorescently-conjugated antibodies and their controls are standard reagents used in flow cytometric analysis and immunological research. The contract represents a consumable supplies purchase for what appears to be an academic research initiative at the University of Virginia's facility in Virginia. All six line items are individual units priced between $63.00 and $136.50, with unit prices reflecting typical academic research pricing for specialized monoclonal antibody products from commercial biotechnology suppliers.